ClinicalTrials.govpublic full text
Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease
leukemia, myelodysplastic syndrome, mds, low- or intermediate-1-risk, chronic myelomonocytic leukemia -1, cmml-1, quality of life in myelodysplasia scale, qualms-1, anemia subset of fact, fact-an, questionnaires, surveys
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 896172
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.